Two service members can experience similar traumatic events. Both can suffer a traumatic brain injury. Yet months or years later, their mental health outcomes may look remarkably different. One develops severe symptoms of post-traumatic stress disorder or depression. The other doesn’t. Why?
Researchers have spent years trying to understand why traumatic brain injury, PTSD, and depression so frequently overlap among veterans and service members, and why some people appear more vulnerable to lasting psychiatric symptoms than others.
New research involving more than 1,000 U.S. service members may have uncovered another piece of that puzzle. Scientists found that naturally occurring antibodies in the blood were associated with significantly lower PTSD and depression symptoms following traumatic brain injury. The finding doesn’t mean researchers have discovered a cure, a diagnostic test, or a way to prevent PTSD. But it could help scientists better understand what happens biologically after brain injury and, eventually, why some veterans experience very different outcomes from seemingly similar injuries.
TBI and PTSD Have Long Been Connected …
Traumatic brain injury has become one of the signature injuries associated with post-9/11 military service. Explosions, blast waves, vehicle accidents, falls, training incidents, and other combat-related events can all cause brain injuries. Some TBIs are immediately obvious. Others are much harder to recognize.
Symptoms can include headaches, dizziness, memory difficulties, concentration problems, sleep disturbances, irritability, sensitivity to light or noise, and changes in mood.
The challenge becomes even more complicated because many of those symptoms can overlap with PTSD and depression. A veteran struggling to sleep, concentrate, remember information, regulate emotions, or tolerate crowded environments may be experiencing effects from TBI, PTSD, depression, or some combination of the three. Untangling those conditions can be difficult for veterans and clinicians alike.
Researchers Looked at More Than 1,000 Service Members
The new study examined more than 1,000 U.S. service members participating in research involving traumatic brain injury and psychological health.
Researchers focused on naturally occurring antibodies known as anti-NMDAR1 antibodies.
NMDAR1 refers to a component of NMDA receptors, which play an important role in communication between nerve cells in the brain and are involved in processes including learning, memory, and the brain’s response to injury. Scientists wanted to know whether naturally occurring levels of these antibodies might be associated with psychological outcomes following TBI. What they found was intriguing.
Among service members who had sustained traumatic brain injury, participants with the highest concentrations of anti-NMDAR1 antibodies had approximately:
- 22% lower PTSD symptom scores
- 25% lower depression symptom scores
… Compared with participants who had the lowest antibody concentrations.
Researchers did not observe the same relationship among participants who had not experienced traumatic brain injury. That distinction is important. It suggests the antibodies may interact with biological processes occurring specifically after brain injury.
VA National Center for PTSD: Traumatic Brain Injury and PTSD.
Could the Body Be Protecting the Brain?
Researchers believe the findings may point toward a naturally occurring protective response.
After a traumatic brain injury, changes to the blood-brain barrier can allow substances in the bloodstream to interact with the brain differently than they normally would. The researchers theorize that anti-NMDAR1 antibodies may influence NMDA receptor activity following injury in a way that reduces some of the biological processes associated with later psychiatric symptoms. In simpler terms: Some people’s bodies may respond to brain injury in a way that provides a degree of protection against PTSD and depression symptoms.
That’s an exciting possibility.
But it’s still a hypothesis.
Scientists need much more research before they’ll understand exactly what these antibodies are doing, why some people have higher concentrations than others, and whether the relationship could someday be used clinically.
What This Study Does NOT Mean …
Research headlines involving PTSD can easily get ahead of the science. So let’s be clear. This study does not mean doctors can perform a blood test and determine whether a veteran will develop PTSD. It does not mean veterans with certain antibody levels are protected from mental illness. It does not mean anti-NMDAR1 antibodies can currently be given as a treatment. And it certainly doesn’t mean PTSD after military trauma is simply the result of having the “wrong” biology.
PTSD is complex. Genetics, trauma severity, repeated exposure, previous experiences, social support, physical injury, sleep, neurological changes, and countless other factors may influence how someone responds to trauma. The new research identifies one possible biological factor among many.
Why This Matters for Veterans
For veterans, the significance of research like this goes beyond one antibody. For decades, PTSD was frequently discussed almost entirely as a psychological response to trauma. Modern research increasingly shows that the relationship between the brain, the immune system, physical injury, stress, and mental health is much more complicated. That matters particularly for veterans with traumatic brain injuries.
A blast injury doesn’t necessarily end when the headache disappears. Changes occurring inside the brain and body may influence symptoms months or even years later. Understanding those biological pathways could eventually help researchers develop better ways to identify risk, distinguish overlapping conditions, and personalize treatment.
Instead of asking only:
“What symptoms does this veteran have?”
Future medicine may increasingly ask:
“What is happening biologically that could be contributing to those symptoms?”
TBI Follow-Up Remains Critically Important
This research arrives at an especially relevant time.
DisabledVeterans.org recently reported on a VA Office of Inspector General investigation that found significant gaps in follow-up care after veterans screened positive for possible traumatic brain injury.
The VA successfully screened the overwhelming majority of eligible post-9/11 veterans reviewed by investigators. But approximately half of veterans who screened positive, agreed to further evaluation, and should have received a comprehensive TBI assessment never received one. That finding reinforced something this new research makes even more important: Traumatic brain injury can have consequences that aren’t immediately obvious. Proper evaluation and follow-up aren’t bureaucratic formalities. They’re opportunities to identify neurological, psychological, and functional problems that may otherwise go untreated.
Research Is Moving Toward More Personalized Care
One of the most promising aspects of modern veteran health research is the shift away from assuming every patient will respond to trauma or treatment the same way.
Two veterans can experience similar injuries and develop completely different symptoms. Two veterans diagnosed with PTSD may respond differently to the same therapy. One person may recover relatively quickly from a mild TBI while another experiences persistent symptoms for years.
Biological markers could eventually help researchers understand some of those differences. If scientists can identify factors associated with greater risk or resilience after traumatic brain injury, clinicians may someday be able to tailor monitoring and treatment more precisely to the individual veteran.
We’re not there yet.
But studies like this help move the science in that direction.
What Veterans Should Do Today …
None of these findings change current VA treatment recommendations.
Veterans who have experienced a head injury or blast exposure and continue to experience headaches, memory difficulties, concentration problems, mood changes, sleep disturbances, dizziness, or other persistent symptoms should discuss those concerns with a healthcare provider.
Likewise, veterans experiencing PTSD or depression symptoms shouldn’t wait for science to discover the perfect biological explanation before seeking help. Effective treatments and specialized VA programs already exist. Veterans receiving VA healthcare can speak with their primary care team about TBI evaluation, mental health services, Polytrauma care, rehabilitation, and other available resources. Research may change tomorrow’s medicine. Veterans still deserve appropriate care today.
Final Thoughts …
Perhaps the most interesting thing about this research isn’t the antibody itself. It’s what the finding represents.
We’re continuing to learn that the dividing line between “physical injury” and “mental health” isn’t nearly as clean as we once imagined. The brain is part of the body. Trauma can affect both. And traumatic brain injury may set off biological processes that influence psychological health long after the initial injury occurred.
Scientists have now identified one naturally occurring antibody associated with substantially lower PTSD and depression symptom scores among service members who experienced TBI.
What that ultimately means remains unknown. But every biological clue brings researchers another step closer to understanding why some veterans struggle after brain injury, why others show greater resilience, and how medicine might someday provide more individualized care to both.
For millions of veterans affected by TBI, PTSD, depression, or combinations of all three, those are questions worth continuing to answer.